Assembly Biosciences ASMB Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Assembly Biosciences's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Assembly Biosciences's total liabilities?
- Assembly Biosciences (ASMB) reported total liabilities of $36.9M in Q1 2026.
- How has Assembly Biosciences's total liabilities changed year-over-year?
- Assembly Biosciences's total liabilities decreased by 48.7% year-over-year, from $71.88M to $36.9M.
- What is the long-term trend for Assembly Biosciences's total liabilities?
- Over 5 years (2020 to 2025), Assembly Biosciences's total liabilities has grown at a 3.6% compound annual growth rate (CAGR), from $42.68M to $50.84M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.